Biggest midday stock movers: Netflix, Apple, CVS Health, Lamb Weston, U.S. Cellular and more
[ad_1] Here are the top stock market movers during midday trading, showing significant changes in their value. [ad_2]
Continue reading[ad_1] Here are the top stock market movers during midday trading, showing significant changes in their value. [ad_2]
Continue reading[ad_1] Cybersecurity company Wiz is aiming to reach $1 billion in annual recurring revenue next year, according to co-founder Roy Reznik. The company, which was founded by former members of…
Continue reading[ad_1] Despite the popularity of exchange-traded funds (ETFs) among investors, these investment vehicles have yet to make significant inroads with 401(k) plan participants. ETFs have grown to about $10 trillion…
Continue reading[ad_1] In after-hours trading, several companies saw movement in their stock prices. Netflix soared over 4% following better-than-expected third-quarter earnings. Intuitive Surgical also experienced a 5% jump after surpassing analyst…
Continue reading[ad_1] Shares of Taiwan Semiconductor surged 12% after reporting a 54% gain in net profit for the third quarter driven by strong demand in artificial intelligence. The positive news also…
Continue reading[ad_1] Shares of Elevance Health dropped more than 10% after the health insurer reported lower-than-expected third-quarter earnings. Despite facing challenges in the Medicaid business, CEO Gail Boudreaux expressed confidence in…
Continue reading[ad_1] Retail brokerage firm Robinhood is introducing a new tool aimed at sophisticated traders to expand its growth opportunities. The new offering, called Robinhood Legend, is a desktop platform designed…
Continue reading[ad_1] Cisco Systems saw a nearly 2% increase in their stock following a buy upgrade from Citi to neutral, stating that artificial intelligence could play a larger role in the…
Continue reading[ad_1] In after-hours trading, several companies made headlines for their performance. Discover Financial saw a 1% decrease in shares despite surpassing expectations with third-quarter earnings of $3.69 per share on…
Continue reading[ad_1] Novavax’s shares plummeted over 17% following the news that the U.S. Food and Drug Administration placed a clinical hold on its application for a Covid and influenza combination shot….
Continue reading